Skip to main content

Neurocognitive deficits and socioeconomic risk factors among children and adolescents living with HIV in sub-Saharan Africa: a systematic review

Abstract

Introduction

Children and adolescents living with HIV (C/ALHIV) are at a risk for significant neurocognitive deficits. There is limited literature that addresses the role of socioeconomic factors in neurocognitive deficits among CALHIV in Sub Saharan Africa (SSA), as it is very difficult to establish this causal relationship. Our systematic review was guided by the biodevelopmental framework that assumes that foundations of health and adversity affect later development and life outcomes. This systematic review aims to assess available evidence on the relationship between neurocognitive deficits and socioeconomic factors among HIV children and adolescents in SSA region.

Method

Using a pre-determined search strategy, we searched electronic databases including PubMed, web of Science and EBSCOhost (CINAHL and MEDLINE). Peer-reviewed publications that address neurocognitive deficits, psychosocial and socioeconomic risk factors among children and adolescents living with HIV in SSA were included in review.

Results

Out of 640 articles, 17 studies from SSA met the inclusion criteria. Four studies reported no significant differences in the neurocognitive measures comparing children and adolescents with HIV infection to those uninfected. However, 10 studies suggest that C/ALHIV scored significantly low in general intellectual functions as compared to their uninfected peers. C/ALHIV were found to have substantial deficits in specific cognitive domains such as sequential processing, simultaneous processing, and learning. In addition, deficits in visuo-spatial processing, visual memory and semantic fluency were mentioned. Socioeconomic factors such as lower socioeconomic status (income, education and occupation), child orphanhood status and under-nutrition were linked with neurocognitive deficits.

Conclusion

Our findings suggest that CALHIV presented with poorer neurocognitive outcomes when compared to other populations which were associated with specific socioeconomic factors.

Introduction

Children and adolescents living with HIV (C/ALHIV) are at high risk of developing neurocognitive deficits. Sub Saharan Africa (SSA) has the highest number of HIV infections of any region in the world, with an estimate of 460,000 (1–45) newly infected with HIV. In the era of increased uptake of Highly Active Antiretroviral Therapy (HAART), the child and adolescent survival rates have improved. However, current research indicates that neurocognitive deficits and associated morbidities persist [1,2,3].

High prevalence of poor neurocognitive functioning among C/ALHIV has been consistently reported in studies in SSA [4,5,6,7] with neurocognitive deficits as early as infancy [8, 9] in preschool [10] and in school aged children [11]. C/ALHIV are likely to show cognitive deficits in specific domains such as attention, processing speed, language, motor skills, learning and memory, visual spatial abilities and executive functioning [12,13,14]. Socioeconomic factors and psychosocial outcomes play an important role in cognitive outcomes of C/ALHIV [2, 11, 15]. This has led to a debate whether these cognitive deficitsstem from HIV or rather, are a result of socioeconomic factors affecting young people in particular, such as home environment [16].

Previous meta-analyses and systematic review have addressed the following areas; i) the extent of cognitive impairment in perinatally HIV infected children and adolescents compared to HIV negative controls and specific domains commonly affected [17], ii) neuropsychological tools focusing on norming and adaptation in SSA [18] and iii) interventions for children with neurocognitive impairments in resourceslimited settings [19]. There is a paucity of data that addresses children and adolescents (10–24 years) compared to studies done among younger ages, even though neurocognitive deficits may persists in adolescence and adulthood [16]. The following question is the focus of this review: Is there an impact of socioeconomic factors, psychosocial outcomes and HIV biomedical factors on neurocognitive functioning in C/ALHIV in SSA region?

Our systematic review was guided by the biodevelopmental framework developed by Shonkoff [20] which assumes that foundations of health and adversity affect later development and life outcomes. These outcomes are in turn influenced by the cumulative burden of risk factors and the buffering effects of protective factors within the environment of an individual. Positive early experiences are vital for healthy development and adaptation. In extending this framework, Shonkoff and Phillips [21] state that families and communities play a vital role in providing supportive relationships and positive learning experiences that young children need for healthy development. Therefore, this model is important in understanding HIV related challenges faced by C/ALHIV as well as expected clinical, cognitive and mental health outcomes. Illustrated in Fig. 1 are the pathways modelling the key factors faced by C/ALHIV in SSA.

Fig. 1
figure 1

Bio-developmental framework by Shonkoff [Source: Shonkoff, 20]

Methods

The PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses guidelines [22] was used to guide the systematic review and checklist by Joanna Briggs Institute (JBI)) [23]. We started the search on the 30th May 2020. After completion of the search on the 2nd April 2021, quality assessment and writing of the review commenced. The review itself was completed on 12th August 2021.

Search strategy

We devised a search strategy which included electronic databases of the following sources: PubMed, EBSCOhost (CINAHL and Medline), PsycINFO and [Forward AND backwards snowballing] = (hand-search/control studies). When conducting the searches, search terms were combined using Boolean terms “AND” “OR”. The articles were searched using the following keywords (See Table 1.).

Table 1 Search strategy

In terms of PICOS: Children and adolescents living with HIV (Population) Socioeconomic risk factors (Intervention) HIV Unexposed Uninfected, HIV exposed Uninfected comparably high poverty sample (Comparative/ Control intervention) Neurocognitive (Outcomes) and Cross-sectional studies, case control, cohort studies and clinical trials (study designs).

Inclusion criteria

Studies were included when they met the following criteria: (a) children and adolescents living with HIV between the ages 6 to 18 years. (b) Neuropsychological test measure was used OR cognitive outcome reported in the study. (c) Study conducted in SSA. (d) Socioeconomic and psychosocial risk factors were assessed using socio demographics questionnaire or psychological tools.

Exclusion criteria

This review did not include studies that were not published in the English language. The time restriction was not included due to limited number studies on neurocognitive functioning and socioeconomic challenges in SSA.

Selection process

The search identified 640 articles (see Fig. 2). The initial screening was done by two independent reviews (JM and OM) based on the title, abstract with reference to inclusion and exclusion criteria. Each reviewer screened titles and then abstracts to select the articles that met the inclusion criteria. Those articles that did not meet the inclusion and exclusion criteria were excluded. Full texts of 37 articles were reviewed and lead to the elimination of 20 articles that did not meet the inclusion criteria. After completed screening, two reviewers (JM and OM) met to seek consensus on the selected articles. As a result, 17 articles initially met the inclusion criteria and were eligible for the review (see Fig. 2). The next stage involved capturing all articles that were relevant on the first screening using a structured Microsoft excel spreadsheet developed by the study team. Articles were downloaded for in-depth review and two reviewers (JM and OM) examined the full texts again to make a final decision regarding inclusion according to the eligibility criteria. They examined the articles independently and extracted the most relevant information that was included in a spreadsheet. Basic information such as the title, year, author, country, study design, sample, neuropsychological tool, general cognition and specific domains and socioeconomic risk factors were captured. Disagreements between the 2 reviewers regarding the inclusion or exclusion of particular studies were settled by consultation with a third reviewer (MK).

Fig. 2
figure 2

Flow diagram of the study selection process

Quality of study methodology

The methodological guidance for systematic review developed by Joanna Briggs Institute (JBI) was used to assess the quality of the selected studies [23]. All selected studies based on the inclusion criteria were subjected to appraisal by at least 2 reviewers (OM. JM). The purpose of was to assess the methodological quality of a study and to determine the possibility of bias in its design, conduct and analysis.

Main outcome(s)

The review outcome of interest is to assess neurocognitive, neurodevelopment and cognitive functioning domains and to review evidence on whether socioeconomic risk factors are associated with neurocognitive functioning among C/ALHIV. In addition, whether there is an interrelationship that the evidence points to which can inform intervention development or intervention implementation.

Strategy for data synthesis

We conducted a narrative synthesis for all the included studies and all data extracted from the articles were presented narratively in text and summary tables. Similarities and differences in study designs, populations and the outcome measures were highlighted and patterns in the data identified. To report our results accurately, we used the Guidance on the Conduct of Narrative Synthesis in Systematic Reviews developed by Popay et al. [24].

Results

Our systematic review yielded seventeen eligible studies. The PRISMA flowchart below provides the details of the study selection process. Six studies originated from Uganda, four studies from Nigeria and one study each from Cameroon, South Africa, Kenya and Zimbabwe. Studies were predominantly based in hospitals, clinics or other healthcare facilities. The sample size ranged from 12 to 611 and participants ranged from 6 to 15 years. The Kaufman Assessment Battery for Children second edition (KABC-II) [25] and Raven’s Progressive Matrices (RPM) [26] tests were the most commonly used neurocognitive assessments. Results are presented according to, (a) the presence of neurocognitive deficits (b) specific domains (c) HIV biomedical outcomes, (d) socioeconomic factors and (e) psychosocial outcomes.

Methodological quality of included reviews

The appraisal results for the included studies are outlined in Table 2. In the critical appraisal checklist, all studies included in the review obtained above 80% “yes” response. They all used validated tools to measure neurocognitive functioning of C/ALHIV in SSA. Musindo et al. did not include a control group [6] and two of the studies [12, 27] had inadequate sample size. Sixteen of the studies clearly described the sampling method, Boivin et al. [28] did not provide adequate sampling procedure information. Overall, all studies included in the review reported measurement of the outcome in a reliable way.

Table 2 Quality of studies

General intellectual functioning (general cognition)

Table 3 summarizes studies reporting general cognition, specific domains and socioeconomic risk factors of C/ALHIV in SSA region. Five different neuropsychological assessments RPM, KABC-II, Wechsler Abbreviated Scale of Intelligence—Second Edition, (WASI-II) and McCarthy Scales of Children’s Abilities (MSCA) were the included studies. These measures assess general cognition and are standardized for the use in children and adolescents [1, 4, 11, 28,29,30,31]. The evidence on general intellectual functioning among C/ALHIV varied across the studies. 10 studies found cognitive deficits among HIV infected children and adolescents as compared to their negative controls (both exposed and unexposed). However, 3 studies reported that there were no significant differences in terms of general intellectual functioning outcomes for the HIV infected and control groups [12, 27, 29, 32].

Table 3 Summary of studies reporting general cognition and specific domains and psychosocial aspects of C/ALHIV in SSA

Specific Cognitive Domains

Seven studies reported significant differences between C/ALHIV and HIV-uninfected controls (both exposed and unexposed), in specific cognitive domains. C/ALHIV performed poorly on simultaneous processing (visual-spatial processing and problem solving), learning (immediate and delayed memory) [5, 28, 29, 33] and sequential processing (memory) [5, 33, 34]. In Zimbabwe, Kandawasvika et al. [32] found that C/ALHIV scored lowest in the perceptual performance domain. In South Africa, Hoare et al. [27] noted lower scores on visuo-spatial processing, visual memory, semantic fluency, motor functioning, processing speed, executive functioning.

Socioeconomic risk factors

Three studies [4, 31, 35] that investigated neurocognitive functioning among C/ALHIV in Nigeria and Cameroon reported that maternal education was associated with neurocognitive outcomes. Boyede et al. [4] found that children of mothers with primary or no education (p = 0.001) were almost three times more likely to have below average RPM scores compared with children of mothers with secondary or tertiary education [1]. In Zimbabwe, orphanhood and caregiver unemployment status (odd ratio of 2.1 (95% CI 1.03–3.4) was associated with low score on MSCA [32]. Caregiver depression and anxiety scores were associated with lower scores on KABC-II [35] while Familiar et al. [36] did not find any association. In addition, Iloh et al. [31] indicated that that socio-economic class (p = 0.028) had significant negative effect on RPM scores of HIV positive children. Undernutrition, stunting and wasting were associated with neurocognitive functioning [12, 32].

Psychosocial Outcomes

Three studies [6, 35, 37] assessed psychosocial outcomes by using child behavior checklist (CBCL), Strength and Difficulty Questionnaire (SDQ) and Home, Education, Activities and peers, Drugs and alcohol, Suicidality, Emotions and behaviours, and Discharge resources (HEADS-ED). A Cameroonian study found that C/ALHIV experienced more behavioral difficulties and this was indicated by higher SDQ scores [35] indicating that they experienced more behavioral difficulties. In addition, SDQ scores were associated with the cognitive scores such as mental processing index, nonverbal index, simultaneous, planning and sequential, learning for children with score ≥ 1 SD compared with the other. Using the HEADS-ED, a study by Musindo et al. [6] found that children and adolescents who are experiencing considerable problems at school and also the greater the dissatisfaction a caregiver expressed about school performance, the lower the scores on mental processing index (overall cognition). There was no association between CBCL behavior/symptom ratings and cognitive scores [37].

HIV Biomedical outcomes

Three studies in Uganda and Nigeria [11, 31, 34] found poor cognitive performance in relation to WHO clinical stages of HIV infection among CALHIV. Significantly lower scores in the RPM among 6–11 years on HAART were associated with worsening WHO clinical stages (p = 0.03) and those not on HAART (p = 0.001). In addition, Iloh et al. [31] found that C/ALHIV with severe suppression (≤ 200 CD4 count cells per millimeter) (0.015) performed poorly on RPM scores. Those with high levels of RNA (Viral load) was associated with poor performance on simultaneous processing while with CD4 cell counts of > 350 cells/μL demonstrate significant cognitive and motor deficits that correlate with HIV plasma RNA level (viral load) [34].

Discussion

We identified 17 studies that highlighted neurocognitive and socioeconomic risk factor faced by C/ALHIV in SSA. C/ALHIV presented with poorer neurocognitive outcomes when compared to other populations which were associated with socioeconomic factors [4, 29, 31, 32, 34, 37].The majority of studies used KABC and RPM to measure neurocognitive outcomes. Van Wyhe et al. [38] confirm that KABC-II can be used widely across different countries due to its strong psychometric properties and cultural appropriateness. The RPM has been validated among the Nigerian children [39], however, there is a controversy about its cultural equivalence [40].Therefore, these measures provided critical information on neurocognitive functioning. However, there is a need to develop local instruments that can provide precise understanding of neurocognitive functioning.

Our findings indicate that there is conflicting evidence of cognitive performance among C/ALHIV. Some of the studies found that C/ALHIV perform more poorly in neurodevelopmental assessments than uninfected controls [4], although in some, no significant differences between groups [12, 27, 29, 32]. Smith et al. [41] explains that differences in the neurocognitive outcomes may be attributed to the HIV biomarkers (Viral load, CD4 count and WHO clinical stage). The lack of routine screening for this population makes it impossible to provide accurate detection and better understanding of neurocognitive deficits for further intervention in SSA. There is need for culturally sensitive tool or adaptation of tools from those initially developed in the West [32], however, developing a new tool is complex and expensive especially in resource-limited settings.

C/ALHIV have shown substantial deficits in cognitive domains such as sequential processing, simultaneous processing and learning [28]. Therefore, C/ALHIV have deficits in both general intellectual functioning to severe deficits in specific cognitive domains and “when assessing the cognitive functioning of children with HIV, it is imperative to examine both global (e.g. intelligence quotient) and specific (e.g. processing speed, visual-spatial) domains of functioning [42].” Our findings suggest an association between poor cognitive performance and World Health Organization clinical stages of HIV infection among C/ALHIV [11, 31, 34] ongoing cognitive decline regardless of being on medication and the undetectable viral load [4]. This is supported by Ravindran et al. [2] and Jeremy et al. [43], however, Laughton et al. [44] found that infants who received ART before 3 months of age had better neurodevelopmental scores compared to infants for whom ART was delayed. Long term use of HAART in young children have been linked to improved neurocognitive outcomes [10].

Our findings suggests that low socioeconomic background contribute to poor neurocognitive outcomes in children infected with HIV [1, 31, 32]. This finding concurs with Ravindran, Rani and Priya [2], Abubakar et al. [45] and Coscia et al. [16]. Boivin et al. [5] concluded that younger children, who come from poor rural areas tend to be stunted, lacked preschool education and that parents’ educational level is important. SES influences availability of cognitive stimulation in the home, this includes such books, computers and many more. This suggests that educated mothers provide a cognitively stimulating environment that is conducive to cognitive improvement in children and adolescents.

The bio-developmental framework concurs that a safe environment and consistent presence of stable caring adults are critical for social and cognitive development that they can use throughout their lives [20]. The caregiver is the most critical person and Shonkoff [20] describes caregiver in the home or institutional setting as the people who relate closely with children such as individual and groups within a community, in school, and in health facilities. This is clear indication that there is need to strengthen home and family environment by focusing on empowering caregivers of C/ALHIV and training them on ways to improve psychosocial and neurocognitive function. A previous study by Boivin et al. [8] showed that neurocognitive deficits among HIV infected in SSA are more likely to be pathophysiology of HIV infection but also poor nutrition and home environment. However, our systematic review failed to assess other factors which are highlighted by the biodevelopmental framework such as exposure to substance and secondary infections in utero, prematurity and birth weight, early experiences of trauma which influence neurocognitive outcomes [20]. We do think that these areas warrant further exploration and the need to address the psychosocial and home environment context of children living with HIV.

Limitations of the study

One limitation of this systematic review is the significant heterogeneity in study designs and reported outcomes, which limited comparisons between the results and conclusions across the articles. Our systematic review did not include other factors which are highlighted by the bio-developmental framework such as exposure to substance and secondary infections in utero, prematurity and birth weight, early experiences of trauma which influence neurocognitive outcomes. We do think that these areas warrant further exploration and the need to address the psychosocial and home environment context of children living with HIV.

Conclusion

This systematic review has important implications for clinical and public health interventions for C/ALHIV. It highlights some of the psychosocial factors, HIV biomedical outcomes and most importantly socioeconomic risk factors that are associated with poor neurocognitive functioning. Given the fact that HIV continues to create a significant burden in the region, there is need for further research and tailored neurocognitive interventions that focus on socioeconomic risk factors. In addition, there is a need to locally developed and validated neurocognitive tests that are culturally appropriate for use in this population in the SSA region.

Availability of data and materials

All data generated or analyzed during this study are included in this published article.

Abbreviations

C/ALHIV:

Children and adolescents living with HIV

HAART:

Highly Active Antiretroviral Therapy

SSA:

Sub Saharan Africa

KABC-II:

Kaufman Assessment Battery for children-Second Edition

RPM:

Raven’s Progressive Matrices

WASI-II:

Wechsler Abbreviated Scale of Intelligence—Second Edition

MSCA:

McCarthy Scales of Children’s Abilities

SDQ:

Strength and Difficulty Questionnaire

References

  1. O Boyede G. The Influence of Clinical Staging and Use of Antiretroviral Therapy on Cognitive Functioning of School-Aged Nigerian Children with HIV Infection. J AIDS Clin Res [Internet]. 2013;04(02). https://www.omicsonline.org/the-influence-of-clinical-staging-and-use-of-antiretroviral-therapy-on-cognitive-functioning-of-school-aged-nigerian-children-with-hiv-infection-2155-6113.1000195.php?aid=11668.

  2. Ravindran OS, Rani MP, Priya G. Cognitive Deficits in HIV Infected Children. Indian J Psychol Med. 2014;36(3):255–9.

    CAS  Article  Google Scholar 

  3. Puthanakit T, Aurpibul L, Louthrenoo O, Tapanya P, Nadsasarn R, Insee-ard S, et al. Poor cognitive functioning of school-aged children in thailand with perinatally acquired HIV infection taking antiretroviral therapy. AIDS Patient Care STDS. 2010;24(3):141–6. https://doi.org/10.1089/apc.2009.0314.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Boyede GO, Lesi FEA, Ezeaka CV, Umeh CS. The Neurocognitive Assessment of HIV-Infected School-Aged Nigerian Children. World J AIDS. 2013;03(02):124–30. https://doi.org/10.4236/wja.2013.32017.

    Article  Google Scholar 

  5. Boivin MJ, Barlow-Mosha L, Chernoff MC, Laughton B, Zimmer B, Joyce C, et al. Neuropsychological performance in African children with HIV enrolled in a multisite antiretroviral clinical trial. AIDS. 2018 Jan 14;32(2):189–204. https://journals.lww.com/00002030-201801140-00007.

  6. Musindo O, Bangirana P, Kigamwa P, Okoth R, Kumar M. Neurocognitive functioning of HIV positive children attending the comprehensive care clinic at Kenyatta national hospital: exploring neurocognitive deficits and psychosocial risk factors. AIDS Care. 2018;30(5):618–22. https://doi.org/10.1080/09540121.2018.1426829.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Hoare J, Fouche J-P, Phillips N, Joska JA, Myer L, Zar HJ, et al. Structural brain changes in perinatally HIV-infected young adolescents in South Africa. AIDS. 2018;32(18):2707–18. https://journals.lww.com/00002030-201811280-00006.

  8. Boivin MJ, Green SDR, Davies AG, Giordani B, et al. A preliminary evaluation of the cognitive and motor effects on pediatric HIV infection in Zairian children. Heal Psychol. 1995;14(1):13–21.

    CAS  Article  Google Scholar 

  9. Van Rie A, Mupuala A, Dow A. Impact of the HIV/AIDS epidemic on the neurodevelopment of preschool-aged children in Kinshasa Democratic Republic of the Congo. Pediatrics. 2008;122(1):e123-8.

    Article  Google Scholar 

  10. Brahmbhatt H, Boivin M, Ssempijja V, Kigozi G, Kagaayi J, Serwadda D, et al. Neurodevelopmental Benefits of Antiretroviral Therapy in Ugandan Children Aged 0–6 Years With HIV. JAIDS J Acquir Immune Defic Syndr. 2014;67(3):316–22. https://journals.lww.com/00126334-201411010-00013.

  11. Boyede G, Lesi, Ezeaka C, Umeh. Impact of sociodemographic factors on cognitive function in school-aged HIV-infected Nigerian children. HIV/AIDS - Res Palliat Care. 2013;145. http://www.dovepress.com/impact-of-sociodemographic-factors-on-cognitive-function-in-school-age-peer-reviewed-article-HIV.

  12. Bagenda D. Health, Neurologic, and Cognitive Status of HIV-Infected, Long-Surviving, and Antiretroviral-Naive Ugandan Children. Pediatrics. 2006;117(3):729–40. https://doi.org/10.1542/peds.2004-2699.

    Article  PubMed  Google Scholar 

  13. Koekkoek S, de Sonneville LMJ, Wolfs TFW, Licht R, Geelen SPM. Neurocognitive function profile in HIV-infected school-age children. Eur J Paediatr Neurol. 2008;12(4):290–7.

    Article  Google Scholar 

  14. Van Rie A, Harrington PR, Dow A, Robertson K. Neurologic and neurodevelopmental manifestations of pediatric HIV/AIDS: A global perspective. Eur J Paediatr Neurol. 2007;11(1):1–9.

    Article  Google Scholar 

  15. Puthanakit T, Ananworanich J, Vonthanak S, Kosalaraksa P, Hansudewechakul R, van der Lugt J, et al. Cognitive Function and Neurodevelopmental Outcomes in HIV-infected Children Older Than 1 Year of Age Randomized to Early Versus Deferred Antiretroviral Therapy. Pediatr Infect Dis J. 2013;32(5):501–8. https://journals.lww.com/00006454-201305000-00014.

  16. Coscia JM. Effects of home environment, socioeconomic status, and health status on cognitive functioning in children with HIV-1 infection. J Pediatr Psychol. 2001;26(6):321–9. https://doi.org/10.1093/jpepsy/26.6.321.

    CAS  Article  PubMed  Google Scholar 

  17. Phillips N, Amos T, Kuo C, Hoare J, Ipser J, Thomas KGF, et al. HIV-Associated Cognitive Impairment in Perinatally Infected Children: A Meta-analysis. Pediatrics [Internet]. 2016;138(5). Available from: http://www.ncbi.nlm.nih.gov/pubmed/27940772.

  18. Nyamayaro P, Chibanda D, Robbins RN, Hakim J, Gouse H. Assessment of neurocognitive deficits in people living with HIV in Sub Saharan Africa: a systematic review. Clin Neuropsychol. 2019;33(sup1):1–26. https://doi.org/10.1080/13854046.2019.1606284.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Van Pelt AE, Lipow MI, Scott JC, Lowenthal ED. Interventions for children with neurocognitive impairments in resource-limited settings: a systematic review. Child Youth Serv Rev. 2020;118:1.

    Google Scholar 

  20. Shonkoff JP. Building a new biodevelopmental framework to guide the future of early childhood policy. Child Dev. 2010;81(1):357–67. https://doi.org/10.1111/j.1467-8624.2009.01399.x.

    Article  PubMed  Google Scholar 

  21. Shonkoff JP, Phillips DA. From Neurons to Neighborhoods: The Science of Early Childhood Development [Internet]. Shonkoff, Jack P., Ed.; Phillips DA, editor. National Academy of Sciences National Research Council, Washington, DC. Board on Children and Families.; Institute of Medicine (NAS), Washington, DC. 2001 [cited 2022 Feb 10]. 1–561 p. https://files.eric.ed.gov/fulltext/ED446866.pdf.

  22. Mantilla-Herrera AM ,Erskine. HE. SJ. SDF. FAJ. Systematic literature review protocol : guide to conducting a systematic review for mental disorders in the Global Burden of Disease study. 2019 [cited 2021 Aug 12]. p. 1–21. https://nla.gov.au/nla.obj-1320780260/view.

  23. Lockwood C, Munn Z, Porritt K. Qualitative research synthesis. Int J Evid Based Healthc. 2015;13(3):179–87.

    Article  Google Scholar 

  24. Popay J, Roberts H, Sowden A, Petticrew M, Arai L, Rodgers M, et al. Guidance on the conduct of narrative synthesis in systematic Reviews. A Product from the ESRC Methods Programme. Version 1. In 2006.

  25. Kaufman AS, Lichtenberger EO, Fletcher-Janzen E, Kaufman NL. Essentials of KABC-II assessment. J. Wiley; 2005. 1–416 p.

  26. Raven J., Raven JC, JH Court. Raven: Standard Progressive Matrices: Sets A, B, C, D & E - Google Scholar. Lewis HK, London. 1958 [cited 2021 Aug 12]. https://scholar.google.com/scholar_lookup?hl=en&publication_year=1958&author=J.+C.+Raven&title=Standard+Progressive+Matrices.

  27. Hoare J, Fouche J-P, Spottiswoode B, Donald K, Philipps N, Bezuidenhout H, et al. A diffusion tensor imaging and neurocognitive study of HIV-positive children who are HAART-naïve “slow progressors.” J Neurovirol. 2012;18(3):205–12. https://doi.org/10.1007/s13365-012-0099-9.

    Article  PubMed  Google Scholar 

  28. MJ B, TD R, HE B, Bangirana P, Cao H, LA E, et al. HIV-subtype A is associated with poorer neuropsychological performance compared with subtype D in antiretroviral therapy-naive Ugandan children. LK - https://vu.on.worldcat.org/oclc/610052952. AIDS (London, England) TA - TT -. 2010;24(8):1163–70.

  29. Brahmbhatt H, Boivin M, Ssempijja V, Kagaayi J, Kigozi G, Serwadda D, et al. Impact of HIV and Atiretroviral Therapy on Neurocognitive Outcomes Among School-Aged Children. JAIDS J Acquir Immune Defic Syndr. 2017;75(1):1–8. https://journals.lww.com/00126334-201705010-00001.

  30. Boivin MJ, Busman RA, Parikh SM, Bangirana P, Page CF, Opoka RO, et al. A pilot study of the neuropsychological benefits of computerized cognitive rehabilitation in Ugandan children with HIV. Neuropsychology. 2010;24(5):667–73. https://doi.org/10.1037/a0019312.

    Article  PubMed  Google Scholar 

  31. Iloh KK, Emodi IJ, Ibeziako NS, Ikefuna AN, Ubesie AC, Iloh ON, et al. Neurocognitive Function of School-aged HIV-infected Children in Enugu Nigeria. J Trop Pediatr. 2017;63(6):425–30.

    Article  Google Scholar 

  32. Kandawasvika GQ, Kuona P, Chandiwana P, Masanganise M, Gumbo FZ, Mapingure MP, et al. The burden and predictors of cognitive impairment among 6- to 8-year-old children infected and uninfected with HIV from Harare, Zimbabwe: A cross-sectional study. Child Neuropsychol. 2015;21(1):106–20. https://doi.org/10.1080/09297049.2013.876493.

    CAS  Article  PubMed  Google Scholar 

  33. Boivin MJ, Chernoff M, Fairlie L, Laughton B, Zimmer B, Joyce C, et al. African Multi-Site 2-Year Neuropsychological Study of School-Age Children Perinatally Infected, Exposed, and Unexposed to Human Immunodeficiency Virus. Clin Infect Dis. 2020;71(7):e105–14. https://academic.oup.com/cid/article/71/7/e105/5649306.

  34. Ruel TD, Boivin MJ, Boal HE, Bangirana P, Charlebois E, Havlir DV, et al. Neurocognitive and Motor Deficits in HIV-Infected Ugandan Children With High CD4 Cell Counts. Clin Infect Dis. 2012;54(7):1001–9. https://doi.org/10.1093/cid/cir1037.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Debeaudrap P, Bodeau-Livinec F, Pasquier E, Germanaud D, Ndiang ST, Nlend AN, et al. Neurodevelopmental outcomes in HIV-infected and uninfected African children. AIDS. 2018;32(18):2749–57. https://journals.lww.com/00002030-201811280-00010.

  36. Familiar I, Chernoff M, Ruisenor-Escudero H, Laughton B, Joyce C, Fairlie L, et al. Association between caregiver depression symptoms and child executive functioning Results from an observational study carried out in four sub-Saharan countries. AIDS Care. 2020;32(4):486–94. https://doi.org/10.1080/09540121.2019.1659917.

    Article  PubMed  Google Scholar 

  37. Boivin MJ, Nakasujja N, Sikorskii A, Opoka RO, Giordani B. A Randomized Controlled Trial to Evaluate if Computerized Cognitive Rehabilitation Improves Neurocognition in Ugandan Children with HIV. AIDS Res Hum Retroviruses. 2016;32(8):743–55. https://doi.org/10.1089/aid.2016.0026.

    Article  PubMed  PubMed Central  Google Scholar 

  38. van Wyhe KS, van de Water T, Boivin MJ, Cotton MF, Thomas KG. Cross-cultural assessment of HIV-associated cognitive impairment using the Kaufman assessment battery for children: a systematic review. J Int AIDS Soc. 2017;20(1):21412. https://doi.org/10.7448/IAS.20.1.21412.

    Article  PubMed  Google Scholar 

  39. Ogunlade JO. The Predictive Validity of the Raven Progressive Matrices With Some Nigerian Children. Educ Psychol Meas. 1978;38(2):465–7. https://doi.org/10.1177/001316447803800232.

    Article  Google Scholar 

  40. A L-R, AF F, I I-C, F C-Q, M P-G, MN P-M. Cultural Bias in Intelligence Assessment Using a Culture-Free Test in Moroccan Children. Arch Clin Neuropsychol. 2021. https://europepmc.org/article/med/33604599.

  41. Smith R. Effects of Perinatal HIV infection and associated risk factors on cognitive development among young children. Pediatrics. 2006;117(3):851–62. https://doi.org/10.1542/peds.2005-0804.

    Article  PubMed  Google Scholar 

  42. Busman RA, Oka E, Giordani B, Boivin MJ. Examining the psychosocial adjustment and school performance of Ugandan children with HIV/AIDS. Neuropsychol Child Africa Perspect Risk Resil. 2013;1:117–38.

    Article  Google Scholar 

  43. Jeremy RJ. Neuropsychological functioning and viral load in stable antiretroviral therapy-experienced HIV-Infected Children. Pediatrics. 2005;115(2):380–7. https://doi.org/10.1542/peds.2004-1108.

    Article  PubMed  Google Scholar 

  44. Laughton B, Cornell M, Grove D, Kidd M, Springer PE, Dobbels E, et al. Early antiretroviral therapy improves neurodevelopmental outcomes in infants. AIDS. 2012;26(13):1685–90. https://journals.lww.com/00002030-201208240-00012.

  45. Abubakar A, et al. Paediatric HIV and neurodevelopment in sub-Saharan Africa: a systematic review. Trop Med Int Heal. 2008;13(7):880–7.

    Article  Google Scholar 

Download references

Acknowledgements

We would like to acknowledge the help received from Modhurima Moitra, Keamogetse Tokwe (Librarian) and Kadimo Khutsafalo (Librarian).

Funding

Not applicable.

Author information

Authors and Affiliations

Authors

Contributions

OM and KM conceptualized and designed the review. OM, JM, conducted the initial searches, screened all abstracts, and conducted the data abstraction with help from KM. OM drafted the manuscript. KM, LK, PB, BO, MPG and OM critically reviewed and revised the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Otsetswe Musindo.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors have declared no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Musindo, O., Krabbendam, L., Mutahi, J. et al. Neurocognitive deficits and socioeconomic risk factors among children and adolescents living with HIV in sub-Saharan Africa: a systematic review. Child Adolesc Psychiatry Ment Health 16, 31 (2022). https://doi.org/10.1186/s13034-022-00465-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13034-022-00465-y

Keywords

  • Children and adolescents living with HIV
  • Neurocognitive deficits
  • Socioeconomic factors
  • Systematic review